Search

everythinglearnresearchcommunity

for

Search:↓

A healthy woman got a chest abscess from a fungal infection after gallbladder surgery, which was treated but caused temporary hair loss due to the antifungal medication.

Cronkhite-Canada syndrome is a rare condition causing gut polyps, hair loss, skin changes, and nail issues, often with a poor outlook.

Early-onset colorectal cancer requires better physician awareness, risk-based screening, and stigma reduction to improve patient experiences.

Hemodialysis successfully treated a cat with minoxidil poisoning.

A pet ferret had a serious infection from Mycobacterium xenopi, which can spread to humans.

The document concludes that individuals with a rare genetic disorder linked to the AEBP1 gene may experience a unique type of hair loss and should be monitored for heart issues.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

CBD may help with skin and hair issues, but more research is needed.

Organoids help study and treat genetic diseases, offering personalized medicine and therapy testing.

Ayurvedic treatment may improve quality of life for cancer patients undergoing chemo and radiotherapy.

Early diagnosis, genetic testing, and innovative treatments are crucial for managing complex medical conditions.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Solid lipid nanoparticles are promising for safe and effective drug delivery but need more research for clinical use.